A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.

The S&P 500 edged higher while the Nasdaq dipped after a volatile session on Tuesday as investors gauged inflation data and ...

The series A fundraising is the biggest ever for a European biotech firm, according to the data provider PitchBook.

Stocks received an initial boost after a Labor Department report showed the producer price index rose moderately in December ...

Investors are weighing what a reported gradual rollout of Trump tariff hikes could mean for inflation and the Fed.

Cool wholesale inflation numbers provide only slight relief before Wednesday's release of December Consumer Price Index data.

Investors are weighing what a reported gradual rollout of Trump tariff hikes could mean for inflation and the Fed.

Lilly revised its revenue guidance down 5%, to $13.5 billion, missing consensus of $14 billion by $500 million. But the guidance still represents a 45% increase from the same quarter in 2023. Lilly ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 503.77% and ...

Stock markets were mixed on Tuesday, as traders awaited inflation data from the US and UK due on Wednesday for clues on ...

Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ...